Peer Review History
| Original SubmissionJuly 28, 2021 |
|---|
|
PONE-D-21-24458Susceptibility to disease (tropical theileriosis) is associated with differential expression of host genes that possess motifs recognised by a pathogen DNA binding proteinPLOS ONE Dear Brian, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. First, I'd like to apologize fort he time taken to come to a decision. The first two reviewers submitted their quite favorable reports quickly, but the third reviewer's report has only just came in and you'll see it's quite critical of the mapping and pointed out that if your mapping strategy was misunderstood it's likely that it was poorly described. As handling editor I found also the PCA analysis and particularly its interpretation wasn't sufficiently explained. For example, there was some obvious outliers that were not mentioned and it was not stated whether the PCA analysis was the basis used to decrease to 5 from 6 the number of lines derived from B. taurus ; meaning that you ended up comparing 6 lines derived from B. indicus to 5 lines from B. taurus and how this imbalance might have impacted on the results and your interpretation. So, I've marked the submission down for major revision to give you the opportunity to clarify better the strategies, techniques used and their consequences on the choices you made. Please submit your revised manuscript by Nov 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Gordon Gordon Langsley Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript by Larcombe et al. studies an important topic in Theileria research. Identification of host/parasite associated mechanisms of cattle resistance/tolerance to tropical theileriosis can provide novel control strategies for theileriosis. Both resistant and susceptible animals get infected by Theileria sporozoites but the disease pathology is mild in resistant Sahiwals and Holsteins die of infection. Therefore, comparisons between these two groups of animals could provide new insights into Theileria annulata infection biology and disease. The authors approach was to perform dual RNA-seq on low passages of Theileria annulata transformed cell lines established ex vivo from theileriosis susceptible (Bos taurus, Holstein(Ho)) and resistant (Bos indicus, Sahiwal (Sa)) cattle and looked at host and parasite genes differentially expressed between individuals of each group. Although the paper is descriptive and fully based on bioinformatics analyses, I found the findings on differential binding of TashAT2 to DNA in Holstein and Sahiwal interesting and the results could be useful for further development of projects on TashAT family as candidate host cell manipulator Theileria annulata genes. Here are my specific comments on the manuscript: -In figure 1 some animal samples show great variance and does not cluster with others, I’m aware that these are from individual animals. It would be if the authors discuss the possible reasons behind this variance. Moreover in the same figure we can observe 12 points representing 12 samples (6 Ho versus 6 Sa), but in lines 157-158 (in fig1 legend as well) it is mentioned that 11 cell lines (5 cell lines of Holstein and 6 Sahiwal cattle) was studied for the PCA plot. Either there is an error in the figure or in the number of cell lines studied. -In figure 1 legend Taurus should be taurus. -Concerning differential expression of parasite genes between Sa and Ho, I was wondering if the authors have checked by western blot the protein levels of TashAT2 in nuclear extracts of Sa and Ho cell lines? Although TashAT2 mRNA levels was found not to be differentially expressed, the protein levels could be different (due to stabilization and etc.) More availability of TashAT2 in the host cell nucleus could result in occupation of more sites on DNA possibly leading to changes in gene expression. -In the list of DE parasite genes (S10_File) between Sa and Ho there are several other interesting candidates that are not discussed or mentioned in results section. For example, we know that some of these DE genes (such as SVSPs) have nuclear localization signals and are found to be trafficked to the nucleus and contribute to cell transformation. Specific examples from this list are TA09790 (up in taurus) and TA05560 (up in indicus). This notion gets more importance when we consider T. parva infection. We know that resistance to T. parva have been reported in endemic African breeds cattle breeds and we know that the TashAT family have orthologues in T. parva but Tpsh family in parva lack DNA binding domains, so this means that other DNA-binding parasite proteins (SVSPs?) could also be involved in differential gene expression observed in disease resistant and disease susceptible animals. -I think in the discussion authors can add few sentences concerning future possibilities to study their findings in more details such as comparative ChIP-sep/ChIP-qPCR approaches using anti-TashAT2 antibodies in Ho and Sa derived Theileria transformed cell lines. They might have already tested this. -Lines 277, 278, 279: 1X, 2X and 3X instead of X1, X2 and X3 -I think mentioning COVID-19 several times in the manuscript is not necessary. -It’s better to mention gene IDs of TashATs where they are introduced in the text for the first time. - In lines 227-246 it is not clear whether these analyses were done on host cell genes or on parasite genes. I can imagine it’s the host cell genes? Reviewer #2: In this manuscript, the authors perform RNAseq of Theileria infected cell lines to investigate disease susceptibility of tropical theileriosis. The comparative transcriptome analysis between tolerant (B. indicus, Sahiwal) and susceptible (B. taurus, Holstein) to acute disease identified differential transcriptome signatures whose pathways linked to innate immunity, cholesterol biosynthesis, cancer, and parasite infection. Differentially expressed genes (DEGs) of this comparison partially overlapped previously reported DEGs induced by Theileria infection in the BL20 cell line. Although conclusive parasite factors that cause different disease susceptibilities were not newly identified, the authors found binding motifs of TashAT2 are divergent in the two breeds genomes. In summary, this manuscript is suitable for publication in the journal. However, I have a few requests for corrections before publication. Minor comments Some text is unreadable due to the low resolution, especially figure 3, 4, 7, could you improve it? The sizes of Table 1, 2, 3 are large and I couldn’t read all parts. These tables require modification. Correct “Table S8” to “Table S6” of the legend in S6 Table. Line 61, 1182, 1187, 1196, 1248, 1270: Correct “Vs” to “vs”. Line 672: Correct “susceptible breeds” to “susceptible” breeds. Reviewer #3: Susceptibility to disease (tropical theileriosis) is associated with differential expression of host genes that possess motifs recognized by a pathogen DNA binding protein Author: Shiels et al. In this work, the authors aim to identify host factors associated with susceptibility to tropical theileriosis, a disease caused by Theileria annulata in livestock. To this end, the authors compare RNAseq data from T. annulata-infected cell lines from Bos taurus (a susceptible species/breed to T. annulata infection) with similar data from infected cell lines from Bos indicus (a less susceptible species/breed). If I understand correctly from the methods, both RNAseq datasets were mapped to the Bos taurus genome and gene expression was tehn quantified and compared. The work, as is, has a few key issues which, until addressed, make it hard to determine the significance of the work. In particular: 1. Bos indicus and Bos taurus are referred to as different breeds but their names indicate different species; how divergent are these taxa and how does that translate into genomic and transcriptomic differences? 2. Following from (1), the authors do not account for inherent gene expression differences between species; 3. Following from (1), the authors do not account for differences in mapping efficiency between species to the B. taurus genome. If, in fact, both RNAseq datasets were mapped to the B. taurus genome, it is likely that the data from B. taurus infected cell lines have a mapping success rate to the B. taurus genome that is higher than the reads from B. indicus. 4. If the two species differ significantly in gene expression (#2) or if mapping success differs between species (#3), either of those can, by itself, explain the pattern in Fig 1, as well as many of the differences observed between species for individual genes. Species-specific differences in gene expression may be addressed by subtracting gene expression between infected and uninfected cells of the same species. The impact of genome-wide differences can be addressed by: - Demonstrating that there is no species-specific impact on read mapping success; - If genomic differences do impact read mapping rate, one possible option is to map RNAseq data to each species’ genome and then merge the two expression quantification datasets based on gene orthology. If this is what has been done, please explain. A possibly simpler approach to the question may be to determine, for each host species, differential gene expression between uninfected and infected cell lines, and then compare the two sets of DEGs. The intersection will possibly be host response to infection, which the unique responses in each host may reflect differences in susceptibility. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Shahin Tajeri Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-24458R1 Susceptibility to disease (tropical theileriosis) is associated with differential expression of host genes that possess motifs recognised by a pathogen DNA binding protein PLOS ONE Dear Brian, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As you know there is no proof reading at PLoS One, and as referee #3 requested a limited number of small corrections to the text, I have marked your submission down for minor revision to give you the opportunity to make the minor text changes. Please submit your revised manuscript by Jan 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Gordon Gordon Langsley Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions
Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors have responded all requested correction and the manuscript has been improved. I think this manuscript is acceptable now. Reviewer #3: Susceptibility to disease (tropical theileriosis) is associated with differential expression of host genes that possess motifs recognized by a pathogen DNA binding protein Author: Shiels et al. This is a resubmission of a paper in which authors compare patterns of gene expression in ex vivo Theileria annulata-infected bovine cells lines from cattle breeds susceptible or tolerant to T. annulata infection to identify host and parasite factors that impact the susceptibility phenotype. The authors found plausible links between differences in tolerance and interferon-stimulated gene pathways, production of INFB1, inflammatory responses and oncogenesis. Critically, they identify a motif bound by a parasite gene that is differently distributed in the genome of both breeds. The authors find that genes with differences between breeds in the presence/absence/number of these motifs were enriched for functions potentially connected to infection. This is a well-written paper with several interesting findings, leading to new hypotheses related to interactions between host and parasite, as well as infection susceptibility. This resubmission addresses my previous concerns adequately. Some minor issues: - Pls add a first line to all supplemental word and xls tables with the title of the table - Lack of consistency throughout text in use of versus, vs, vs. (best to use an italicized form, as vs.) - L136, word missing in “offer the best available for“ - L191: change “mapped to the bovine” to “mapped to the Bos taurus” - L319: change “number of reads” to “proportion of reads” (also, see typo in table S3) - L629-630” “Subsequent PANTHER analysis showed”. Which genes were fed to this analysis? All 11,983 from B. taurus? Only the 7,575 shared? Those not shared? ...? The interpretation of the enrichment analysis will be affected. - Fig 7C. I suggest using in Panel C different colors from those in legend in panel B - L707-708: “This result may indicate that a number of infection-associated genes differentially expressed between breeds have been missed by our analysis “ I am not sure I follow. Couldn’t there be constitutively expressed genes, differentially expressed between breeds, regardless of infection status? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Susceptibility to disease (tropical theileriosis) is associated with differential expression of host genes that possess motifs recognised by a pathogen DNA binding protein PONE-D-21-24458R2 Dear Brian, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Gordon Gordon Langsley Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-24458R2 Susceptibility to disease (tropical theileriosis) is associated with differential expression of host genes that possess motifs recognised by a pathogen DNA binding protein Dear Dr. Shiels: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Gordon Langsley Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .